3 weeks Strength Across Segments to Help CAH Stock Offset OptumRx Headwind? Zacks
CAH gains from a solid pharmaceutical segment and a diversified product portfolio. However, concentrated revenue generation and regulatory setbacks are a concern.
Cardinal Health (CAH) · Health
X